Repurposing of FDA Approved Drugs Against SARS-CoV-2 Papain-Like Protease: Computational, Biochemical, and in vitro Studies
FDA 批准的抗 SARS-CoV-2 木瓜蛋白酶样蛋白酶药物的再利用:计算、生化和体外研究
期刊:Frontiers in Microbiology
影响因子:4
doi:10.3389/fmicb.2022.877813
Rajkumar Kulandaisamy, Tushar Kushwaha, Anu Dalal, Vikas Kumar, Deepa Singh, Kamal Baswal, Pratibha Sharma, Kokkula Praneeth, Pankaj Jorwal, Sarala R Kayampeta, Tamanna Sharma, Srinivas Maddur, Manoj Kumar, Saroj Kumar, Aparoy Polamarasetty, Aekagra Singh, Deepak Sehgal, Shivajirao L Gholap, Mohan B